Titre : Cyclopentolate

Cyclopentolate : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment le cyclopentolate est-il utilisé en diagnostic ?

Il est utilisé pour dilater la pupille afin d'examiner le fond de l'œil.
Cyclopentolate Examen ophtalmologique
#2

Quels tests nécessitent le cyclopentolate ?

Il est souvent utilisé avant des tests comme la rétinographie ou l'examen du nerf optique.
Cyclopentolate Rétinographie
#3

Le cyclopentolate est-il utilisé pour diagnostiquer des maladies ?

Non, il ne diagnostique pas, mais facilite l'observation des structures oculaires.
Cyclopentolate Maladies oculaires
#4

Quelle est la durée d'action du cyclopentolate ?

Son effet peut durer de 6 à 24 heures, selon la concentration utilisée.
Cyclopentolate Durée d'action
#5

Le cyclopentolate est-il utilisé en pédiatrie ?

Oui, il est souvent utilisé pour dilater les pupilles chez les enfants lors d'examens.
Cyclopentolate Pédiatrie

Symptômes 5

#1

Quels effets secondaires peuvent survenir avec le cyclopentolate ?

Les effets incluent sécheresse buccale, vision floue et photophobie.
Cyclopentolate Effets secondaires
#2

Le cyclopentolate provoque-t-il des symptômes allergiques ?

Des réactions allergiques sont rares mais peuvent inclure démangeaisons ou éruptions.
Cyclopentolate Réactions allergiques
#3

Quels symptômes indiquent une surdose de cyclopentolate ?

Une surdose peut causer confusion, hallucinations et tachycardie.
Cyclopentolate Surdose
#4

Le cyclopentolate peut-il affecter la vision ?

Oui, il peut provoquer une vision floue temporaire après administration.
Cyclopentolate Vision floue
#5

Quels symptômes sont normaux après l'utilisation du cyclopentolate ?

Une légère irritation oculaire et une dilatation des pupilles sont normales.
Cyclopentolate Irritation oculaire

Prévention 5

#1

Y a-t-il des précautions à prendre avant d'utiliser le cyclopentolate ?

Oui, informez votre médecin de toute allergie ou condition médicale préexistante.
Cyclopentolate Précautions
#2

Comment minimiser les effets secondaires du cyclopentolate ?

Évitez la lumière vive et utilisez des lunettes de soleil après l'application.
Cyclopentolate Effets secondaires
#3

Le cyclopentolate est-il sûr pendant la grossesse ?

Son utilisation doit être évaluée par un médecin, car les données sont limitées.
Cyclopentolate Grossesse
#4

Quelles interactions médicamenteuses sont possibles avec le cyclopentolate ?

Il peut interagir avec d'autres anticholinergiques et certains médicaments pour le cœur.
Cyclopentolate Interactions médicamenteuses
#5

Le cyclopentolate est-il sûr pour les enfants ?

Oui, il est couramment utilisé chez les enfants, mais sous surveillance médicale.
Cyclopentolate Enfants

Traitements 5

#1

Comment le cyclopentolate est-il administré ?

Il est généralement administré sous forme de gouttes oculaires.
Cyclopentolate Gouttes oculaires
#2

Le cyclopentolate est-il utilisé pour traiter des maladies ?

Non, il est utilisé pour la dilatation pupillaire, pas pour traiter des maladies.
Cyclopentolate Traitement
#3

Quelle est la posologie standard du cyclopentolate ?

La posologie varie, mais généralement 1 à 2 gouttes sont administrées avant l'examen.
Cyclopentolate Posologie
#4

Peut-on utiliser le cyclopentolate chez les personnes âgées ?

Oui, mais avec précaution, car ils peuvent être plus sensibles aux effets secondaires.
Cyclopentolate Personnes âgées
#5

Le cyclopentolate nécessite-t-il une prescription ?

Oui, il est généralement prescrit par un professionnel de santé.
Cyclopentolate Prescription

Complications 5

#1

Quelles complications peuvent survenir avec le cyclopentolate ?

Des complications rares incluent une pression intraoculaire élevée ou des réactions allergiques.
Cyclopentolate Complications
#2

Le cyclopentolate peut-il causer des problèmes de vision à long terme ?

Non, il n'est pas associé à des problèmes de vision à long terme lorsqu'il est utilisé correctement.
Cyclopentolate Vision
#3

Comment gérer une réaction indésirable au cyclopentolate ?

Consultez immédiatement un médecin si vous ressentez des symptômes graves ou inhabituels.
Cyclopentolate Réaction indésirable
#4

Le cyclopentolate peut-il aggraver des conditions oculaires existantes ?

Il peut aggraver certaines conditions comme le glaucome, nécessitant une évaluation préalable.
Cyclopentolate Glaucome
#5

Quels signes indiquent une complication après l'utilisation du cyclopentolate ?

Des douleurs oculaires sévères, une vision très floue ou des rougeurs peuvent indiquer une complication.
Cyclopentolate Signes de complication
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cyclopentolate : Questions médicales les plus fréquentes", "headline": "Cyclopentolate : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cyclopentolate : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-05", "dateModified": "2026-02-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cyclopentolate" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Phénylacétates", "url": "https://questionsmedicales.fr/mesh/D010648", "about": { "@type": "MedicalCondition", "name": "Phénylacétates", "code": { "@type": "MedicalCode", "code": "D010648", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.241.223.601" } } }, "about": { "@type": "MedicalCondition", "name": "Cyclopentolate", "alternateName": "Cyclopentolate", "code": { "@type": "MedicalCode", "code": "D003519", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Lisa Jean Kremer", "url": "https://questionsmedicales.fr/author/Lisa%20Jean%20Kremer", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, University of Otago, Dunedin, New Zealand lisa.kremer@otago.ac.nz." } }, { "@type": "Person", "name": "Roland Broadbent", "url": "https://questionsmedicales.fr/author/Roland%20Broadbent", "affiliation": { "@type": "Organization", "name": "Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand." } }, { "@type": "Person", "name": "Natalie Medlicott", "url": "https://questionsmedicales.fr/author/Natalie%20Medlicott", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, University of Otago, Dunedin, New Zealand." } }, { "@type": "Person", "name": "Mary Jane Sime", "url": "https://questionsmedicales.fr/author/Mary%20Jane%20Sime", "affiliation": { "@type": "Organization", "name": "Ophthalmology, Southern District Health Board, Dunedin, New Zealand." } }, { "@type": "Person", "name": "David M Reith", "url": "https://questionsmedicales.fr/author/David%20M%20Reith", "affiliation": { "@type": "Organization", "name": "Department of Women's and Children's Health, University of Otago, Dunedin, New Zealand." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The Effect of Cyclopentolate on Ocular Biometric Components.", "datePublished": "2020-06-00", "url": "https://questionsmedicales.fr/article/32511166", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/OPX.0000000000001524" } }, { "@type": "ScholarlyArticle", "name": "Comparisons of atropine versus cyclopentolate cycloplegia in myopic children.", "datePublished": "2021-Mar-00", "url": "https://questionsmedicales.fr/article/32844483", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/cxo.13128" } }, { "@type": "ScholarlyArticle", "name": "Delirium due to the use of topical cyclopentolate hydrochloride.", "datePublished": "2020-Jan-30", "url": "https://questionsmedicales.fr/article/32057204", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.18071/isz.73.0051" } }, { "@type": "ScholarlyArticle", "name": "Cyclopentolate eye drops-induced anaphylaxis in an infant.", "datePublished": "2022-00-00", "url": "https://questionsmedicales.fr/article/36305442", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.24953/turkjped.2022.125" } }, { "@type": "ScholarlyArticle", "name": "Comparison of retinoscopy results with and without 1% cyclopentolate in school-aged children.", "datePublished": "2019-07-00", "url": "https://questionsmedicales.fr/article/31236978", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/opo.12629" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Acides carboxyliques", "item": "https://questionsmedicales.fr/mesh/D002264" }, { "@type": "ListItem", "position": 4, "name": "Acides carbocycliques", "item": "https://questionsmedicales.fr/mesh/D000146" }, { "@type": "ListItem", "position": 5, "name": "Phénylacétates", "item": "https://questionsmedicales.fr/mesh/D010648" }, { "@type": "ListItem", "position": 6, "name": "Cyclopentolate", "item": "https://questionsmedicales.fr/mesh/D003519" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cyclopentolate - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cyclopentolate", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cyclopentolate", "description": "Comment le cyclopentolate est-il utilisé en diagnostic ?\nQuels tests nécessitent le cyclopentolate ?\nLe cyclopentolate est-il utilisé pour diagnostiquer des maladies ?\nQuelle est la durée d'action du cyclopentolate ?\nLe cyclopentolate est-il utilisé en pédiatrie ?", "url": "https://questionsmedicales.fr/mesh/D003519#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cyclopentolate", "description": "Quels effets secondaires peuvent survenir avec le cyclopentolate ?\nLe cyclopentolate provoque-t-il des symptômes allergiques ?\nQuels symptômes indiquent une surdose de cyclopentolate ?\nLe cyclopentolate peut-il affecter la vision ?\nQuels symptômes sont normaux après l'utilisation du cyclopentolate ?", "url": "https://questionsmedicales.fr/mesh/D003519#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cyclopentolate", "description": "Y a-t-il des précautions à prendre avant d'utiliser le cyclopentolate ?\nComment minimiser les effets secondaires du cyclopentolate ?\nLe cyclopentolate est-il sûr pendant la grossesse ?\nQuelles interactions médicamenteuses sont possibles avec le cyclopentolate ?\nLe cyclopentolate est-il sûr pour les enfants ?", "url": "https://questionsmedicales.fr/mesh/D003519#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cyclopentolate", "description": "Comment le cyclopentolate est-il administré ?\nLe cyclopentolate est-il utilisé pour traiter des maladies ?\nQuelle est la posologie standard du cyclopentolate ?\nPeut-on utiliser le cyclopentolate chez les personnes âgées ?\nLe cyclopentolate nécessite-t-il une prescription ?", "url": "https://questionsmedicales.fr/mesh/D003519#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cyclopentolate", "description": "Quelles complications peuvent survenir avec le cyclopentolate ?\nLe cyclopentolate peut-il causer des problèmes de vision à long terme ?\nComment gérer une réaction indésirable au cyclopentolate ?\nLe cyclopentolate peut-il aggraver des conditions oculaires existantes ?\nQuels signes indiquent une complication après l'utilisation du cyclopentolate ?", "url": "https://questionsmedicales.fr/mesh/D003519#section-complications" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment le cyclopentolate est-il utilisé en diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Il est utilisé pour dilater la pupille afin d'examiner le fond de l'œil." } }, { "@type": "Question", "name": "Quels tests nécessitent le cyclopentolate ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Il est souvent utilisé avant des tests comme la rétinographie ou l'examen du nerf optique." } }, { "@type": "Question", "name": "Le cyclopentolate est-il utilisé pour diagnostiquer des maladies ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, il ne diagnostique pas, mais facilite l'observation des structures oculaires." } }, { "@type": "Question", "name": "Quelle est la durée d'action du cyclopentolate ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Son effet peut durer de 6 à 24 heures, selon la concentration utilisée." } }, { "@type": "Question", "name": "Le cyclopentolate est-il utilisé en pédiatrie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est souvent utilisé pour dilater les pupilles chez les enfants lors d'examens." } }, { "@type": "Question", "name": "Quels effets secondaires peuvent survenir avec le cyclopentolate ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les effets incluent sécheresse buccale, vision floue et photophobie." } }, { "@type": "Question", "name": "Le cyclopentolate provoque-t-il des symptômes allergiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des réactions allergiques sont rares mais peuvent inclure démangeaisons ou éruptions." } }, { "@type": "Question", "name": "Quels symptômes indiquent une surdose de cyclopentolate ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une surdose peut causer confusion, hallucinations et tachycardie." } }, { "@type": "Question", "name": "Le cyclopentolate peut-il affecter la vision ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut provoquer une vision floue temporaire après administration." } }, { "@type": "Question", "name": "Quels symptômes sont normaux après l'utilisation du cyclopentolate ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une légère irritation oculaire et une dilatation des pupilles sont normales." } }, { "@type": "Question", "name": "Y a-t-il des précautions à prendre avant d'utiliser le cyclopentolate ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Oui, informez votre médecin de toute allergie ou condition médicale préexistante." } }, { "@type": "Question", "name": "Comment minimiser les effets secondaires du cyclopentolate ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Évitez la lumière vive et utilisez des lunettes de soleil après l'application." } }, { "@type": "Question", "name": "Le cyclopentolate est-il sûr pendant la grossesse ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Son utilisation doit être évaluée par un médecin, car les données sont limitées." } }, { "@type": "Question", "name": "Quelles interactions médicamenteuses sont possibles avec le cyclopentolate ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Il peut interagir avec d'autres anticholinergiques et certains médicaments pour le cœur." } }, { "@type": "Question", "name": "Le cyclopentolate est-il sûr pour les enfants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est couramment utilisé chez les enfants, mais sous surveillance médicale." } }, { "@type": "Question", "name": "Comment le cyclopentolate est-il administré ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Il est généralement administré sous forme de gouttes oculaires." } }, { "@type": "Question", "name": "Le cyclopentolate est-il utilisé pour traiter des maladies ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, il est utilisé pour la dilatation pupillaire, pas pour traiter des maladies." } }, { "@type": "Question", "name": "Quelle est la posologie standard du cyclopentolate ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La posologie varie, mais généralement 1 à 2 gouttes sont administrées avant l'examen." } }, { "@type": "Question", "name": "Peut-on utiliser le cyclopentolate chez les personnes âgées ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, mais avec précaution, car ils peuvent être plus sensibles aux effets secondaires." } }, { "@type": "Question", "name": "Le cyclopentolate nécessite-t-il une prescription ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est généralement prescrit par un professionnel de santé." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le cyclopentolate ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications rares incluent une pression intraoculaire élevée ou des réactions allergiques." } }, { "@type": "Question", "name": "Le cyclopentolate peut-il causer des problèmes de vision à long terme ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Non, il n'est pas associé à des problèmes de vision à long terme lorsqu'il est utilisé correctement." } }, { "@type": "Question", "name": "Comment gérer une réaction indésirable au cyclopentolate ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Consultez immédiatement un médecin si vous ressentez des symptômes graves ou inhabituels." } }, { "@type": "Question", "name": "Le cyclopentolate peut-il aggraver des conditions oculaires existantes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Il peut aggraver certaines conditions comme le glaucome, nécessitant une évaluation préalable." } }, { "@type": "Question", "name": "Quels signes indiquent une complication après l'utilisation du cyclopentolate ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs oculaires sévères, une vision très floue ou des rougeurs peuvent indiquer une complication." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 23/02/2026

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Lisa Jean Kremer

2 publications dans cette catégorie

Affiliations :
  • School of Pharmacy, University of Otago, Dunedin, New Zealand lisa.kremer@otago.ac.nz.
  • Department of Women's and Children's Health, University of Otago, Dunedin, New Zealand.

Roland Broadbent

2 publications dans cette catégorie

Affiliations :
  • Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

Mary Jane Sime

2 publications dans cette catégorie

Affiliations :
  • Ophthalmology, Southern District Health Board, Dunedin, New Zealand.

David M Reith

2 publications dans cette catégorie

Affiliations :
  • Department of Women's and Children's Health, University of Otago, Dunedin, New Zealand.

Hassan Hashemi

1 publication dans cette catégorie

Affiliations :
  • Noor Research Center for Ophthalmic Epidemiology, Noor Eye Hospital, Tehran, Iran.
Publications dans "Cyclopentolate" :

Amir Asharlous

1 publication dans cette catégorie

Affiliations :
  • Rehabilitation Research Center, Department of Optometry, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
Publications dans "Cyclopentolate" :

Mehdi Khabazkhoob

1 publication dans cette catégorie

Affiliations :
  • Department of Medical Surgical Nursing, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Publications dans "Cyclopentolate" :

Rafael Iribarren

1 publication dans cette catégorie

Affiliations :
  • Immunopathology and Ophthalmology Translational Research Laboratory, Department of Pathology, School of Medicine, University of Buenos Aires, Argentina.
Publications dans "Cyclopentolate" :

Ahmad Khosravi

1 publication dans cette catégorie

Affiliations :
  • Center for Health Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences, Shahroud, Iran.
Publications dans "Cyclopentolate" :

Abbasali Yekta

1 publication dans cette catégorie

Affiliations :
  • Refractive Errors Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Publications dans "Cyclopentolate" :

Mohammad Hassan Emamian

1 publication dans cette catégorie

Publications dans "Cyclopentolate" :

Akbar Fotouhi

1 publication dans cette catégorie

Affiliations :
  • Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Publications dans "Cyclopentolate" :

Mahmut Atum

1 publication dans cette catégorie

Affiliations :
  • Sakarya University Education and Research Hospital, Department of Ophthalmology, Sakarya, Turkey.
Publications dans "Cyclopentolate" :

Erkan Çelik

1 publication dans cette catégorie

Affiliations :
  • Sakarya University Education and Research Hospital, Department of Ophthalmology, Sakarya, Turkey.
Publications dans "Cyclopentolate" :

Gürsoy Alagöz

1 publication dans cette catégorie

Affiliations :
  • Sakarya University Education and Research Hospital, Department of Ophthalmology, Sakarya, Turkey.
Publications dans "Cyclopentolate" :

Luyao Ye

1 publication dans cette catégorie

Affiliations :
  • Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Shanghai Eye Disease Prevention and Treatment Centre, Shanghai Eye Hospital, Shanghai, China.
  • National Clinical Research Centre for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Centre for Visual Science and Photomedicine, Shanghai Engineering Centre for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China.
Publications dans "Cyclopentolate" :

Shanshan Li

1 publication dans cette catégorie

Affiliations :
  • Shanghai Eye Disease Prevention and Treatment Centre, Shanghai Eye Hospital, Shanghai, China.
Publications dans "Cyclopentolate" :

Ya Shi

1 publication dans cette catégorie

Affiliations :
  • Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Shanghai Eye Disease Prevention and Treatment Centre, Shanghai Eye Hospital, Shanghai, China.
  • National Clinical Research Centre for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Centre for Visual Science and Photomedicine, Shanghai Engineering Centre for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China.
Publications dans "Cyclopentolate" :

Yao Yin

1 publication dans cette catégorie

Affiliations :
  • Shanghai Eye Disease Prevention and Treatment Centre, Shanghai Eye Hospital, Shanghai, China.
Publications dans "Cyclopentolate" :

Sources (52 au total)

The Effect of Cyclopentolate on Ocular Biometric Components.

It is apparent that a variety of biometric changes are caused by different types of cycloplegic eye drops. However, these effects are inconsistent and have not been reported in different refractive gr... The purpose of this study was to determine the effect of cyclopentolate 1% on ocular biometric components in different types of refractive errors in children.... This cross-sectional study was conducted on 226 eyes of 113 schoolchildren in Shahroud, northeast Iran, with a mean ± standard deviation age of 9.20 ± 1.65 years. All participants had noncycloplegic a... After cycloplegia, the vitreous chamber depth (VCD) (-0.043; 95% confidence interval [CI], -0.067 to -0.019 mm), lens thickness (-0.146; 95% CI, -0.175 to -0.117 mm), axial length (-0.009; 95% CI, -0.... According to the findings of this study, cycloplegia reduces the thickness of the crystalline lens and subsequently causes an increase in the ACD. Cycloplegia-related ocular biometric changes were dif...

Comparisons of atropine versus cyclopentolate cycloplegia in myopic children.

In clinical practice, 1% atropine and 1% cyclopentolate are used as cycloplegia agents to diagnose refractive error. The influence of 1% atropine on ocular biometry is obscure, and the impact of 1% cy... This study aims to compare the effects of atropine versus cyclopentolate cycloplegia on ocular biometry in myopic children and to determine the sites of action for atropine.... A total of 207 myopic children aged 6-12-years were included in the analysis. All participants underwent comprehensive eye examinations before and after cyclopentolate cycloplegia, after which they we... Cyclopentolate cycloplegia caused a decrease in choroidal thickness (-3 ± 9 μm, p = 0.001), elongation of axial length (9 ± 16 μm, p < 0.001), loss of lens power (-0.14 ± 0.37 dioptre, p < 0.001), and... Cyclopentolate and atropine cycloplegia have different effects on ocular biometry. Both 1% cyclopentolate cycloplegia and 0.01% atropine resulted in choroidal thickening, indicating that the choroid m...

Cyclopentolate eye drops-induced anaphylaxis in an infant.

Cyclopentolate is frequently used as a mydriatic agent during ophthalmological examinations in childhood and hypersensitivity reactions associated with this drug are rare. We aim to report an infant w... A nine-month-old girl, who was being followed up with a diagnosis of retinoblastoma, presented for consultation for urticaria, cough, stridor, and dyspnea that developed after the administration of to... In children, hypersensitivity reactions due to cyclopentolate are very rare. Only four pediatric patients were reported in the literature to have developed an allergic reaction after the administratio...

Comparison of retinoscopy results with and without 1% cyclopentolate in school-aged children.

This study was designed with the aim of providing practitioners with an evidence base to inform their clinical decision making as to when cycloplegic retinoscopy is necessary and when it might be appr... A single examiner carried out cycloplegic and non-cycloplegic retinoscopy on 128 children stratified into four age groups (6-7, 8-9, 10-12 and 12-13 years). Cycloplegia was achieved using 1% cyclopent... Cycloplegic and non-cycloplegic sphere differed significantly (z = -9.18, p < 0.0001). Although the difference decreased significantly as age increased (χ... Cyclopentolate 1% does not impact the cylindrical component of the retinoscopy result, but reveals significantly more hyperopia in the spherical component, both statistically and clinically in childre...

The Effect of Topical Cyclopentolate on Anterior Segment Parameters in Patients with Keratoconus

To investigate the effect of cycloplegia on anterior segment structures in keratoconus and forme fruste keratoconus patients using corneal topography.... In this study, 40 patients with keratoconus (group 1), 40 patients with forme fruste keratoconus (group 2), and 40 healthy subjects (group 3) were evaluated prospectively. Flat keratometry (K) value (... The mean age of the participants was 24.4±6.2 years for group 1, 26.3±4.3 years for group 2 and 26.5±6.1 years for group 3. There was no difference between the groups with respect to mean age and gend... Cycloplegia causes corneal flattening only in manifest keratoconus patients, leading to an increase in ACD in all groups....

Effect of cyclopentolate versus tropicamide on anterior segment angle parameters in three refractive groups.

Frequent clinical application of cycloplegia in clinical practice makes it essential to assess how this condition influences anterior segment angle parameters.... This study aims to compare the effects of cyclopentolate and tropicamide on anterior segment angle parameters in three adult refractive groups.... Sixty healthy individuals were recruited and assigned into three refractive groups according to inclusion criteria. At baseline visit, anterior segment angle parameters were measured using anterior se... Sixty participants (29 men and 31 women, age: 27.82 ± 4.71-years) completed the experiment. Baseline mean spherical equivalents were +1.52 ± 1.20 D, -0.04 ± 0.33 D and -1.91 ± 0.91-D in hyperopic, emm... Topical application of cycloplegic eye drops in healthy individuals leads to small but significant changes in anterior chamber depth and anterior segment angle parameters, regardless of refractive sta...

Comparison of effects of mydriatic drops (1% cyclopentolate and 0.5% tropicamide) on anterior segment parameters.

The purpose of this study is to investigate and compare the effects of cyclopentolate and tropicamide drops on anterior segment parameters in healthy individuals.... Two hundred and fifty-eight eyes of 129 healthy volunteers were included in this randomized clinical study. Cyclopentolate 1% drop was applied to 75 (58%) participants (group 1) and tropicamide 0.5% d... The increase in CCT, ACD, pupil diameter, and pupil offset was significant in group 1 after the drop (P < 0.05), while the increase in ACD, pupil diameter, and pupil offset was significant in group 2 ... The effects of cyclopentolate and tropicamide drops on anterior segment parameters were similar; they did not make significant changes in K1, K2, AL, WTW, and third-generation IOL power calculation. H...

Delirium caused by topical administration of cyclopentolate for cataract surgery in mild cognitive impairment due to Alzheimer's disease: A case report.

Cholinergic modification by anticholinergic medication can produce adverse effects in central nervous system (CNS) and cyclopentolate is an antimuscarinic agent widely used for ophthalmologic manageme... A 74-year-old man showed acute confusion after preparation for cataract operation in day surgery clinic. The patient became confused and agitated after instillation of topical cyclopentolate drop into... Previously the patient had been diagnosed with amnestic MCI with the finding of bilateral medial temporal atrophy on brain magnetic resonance imaging. 18F-flutemetamol positron emission tomography sca... The patient was closely observed with the supportive management.... The patient began to recover 5 h after the onset of symptoms and the cognitive function was reverted to previous state within 24 h.... It is well known that several drugs with anticholinergic effects used in perioperative periods make the patients susceptible to delirium, but even the topical administration of cyclopentolate for cata...

Comparison of cycloplegia with atropine 1% versus cyclopentolate 1.

Cycloplegic refraction is mandatory for children to know the eye's refractive status. In this study, we compared cycloplegia induced by cyclopentolate 1% to that induced by atropine 1% by means of ret... In this parallel-designed interventional study, we included 67 children aged between 4 and 17 years. After the initial retinoscopy under cyclopentolate 1% (used twice in each eye), we repeated it a we... The mean SE with atropine was +1.93 ± 2.0 D, compared to +1.75 ± 1.95 D under cyclopentolate. On average, atropine induced greater cycloplegia by a mere 0.18 D (95% CI: 0.07 to 0.29 D, P value 0.002).... Our study suggests that cyclopentolate works for the most part as well as atropine to attain cycloplegia. Atropine may be considered for children less than 15 years of age with greater than 5.0 D of h...